EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Protease regulation of tumor-immune cell symbiosis

Lizhi Pang, Yuyun Huang, Jean Huang-Gao, Peiwen Chen

Trends in Cancer · 2025

DOI: 10.1016/j.trecan.2025.02.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025. Verfasst von Lizhi Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Peptide Hydrolases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteases play a crucial role in cancer progression and are traditionally known for their protumorigenic role by degrading the extracellular matrix (ECM). Emerging evidence indicates that proteases, such as caspases, cathepsins, and ubiquitin-specific proteases (USPs), regulate diverse immunomodulatory substrates or signals in the tumor microenvironment (TME), generating symbiotic interactions between cancer cells and immune cells. These interactions are critical for tumor progression and immunotherapy resistance across cancer types. In this review, we highlight recent insights into protease-mediated tumor-immune cell crosstalk, emphasizing how this symbiosis affects tumor progression and immunosuppression. Moreover, we discuss therapeutic strategies that exploit protease-mediated tumor-immune cell interactions to inhibit tumor progression and sensitize immunologically 'cold' tumors to immunotherapies, especially immune checkpoint inhibitor (ICI) therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplasmsPeptide HydrolasesHumansAnimalsImmune Checkpoint InhibitorsImmunotherapyExtracellular MatrixCell CommunicationDrug Resistance, NeoplasmSymbiosisDisease Progression

Stichwörter der Autor:innen

immune checkpoint inhibitorimmunotherapyproteasetumor microenvironmenttumor–immune cell crosstalk

Substanzen

Peptide HydrolasesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: CHENP6@ccf.org.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • U.S. Department of Defense
  • NIH

Zitieren

APA

Pang, L., Huang, Y., Huang-Gao, J., & Chen, P. (2025). Protease regulation of tumor-immune cell symbiosis. Trends in Cancer. https://doi.org/10.1016/j.trecan.2025.02.004

Vancouver

Pang L, Huang Y, Huang-Gao J, Chen P. Protease regulation of tumor-immune cell symbiosis. Trends in Cancer. 2025. doi:10.1016/j.trecan.2025.02.004

BibTeX
@article{Pang2025,
  author = {Pang, Lizhi and Huang, Yuyun and Huang-Gao, Jean and Chen, Peiwen},
  title = {Protease regulation of tumor-immune cell symbiosis},
  journal = {Trends in Cancer},
  year = {2025},
  doi = {10.1016/j.trecan.2025.02.004}
}
Kostenlos starten →